Table 1 Correlation between clinicopathological features and SAM68 expression in MIBC patients
From: Utility of SAM68 in the progression and prognosis for bladder cancer
Characteristics | n | SAM68 | Ļ2testP-value | n | SAM68 | Ļ2testP-value | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Low | High | Nucleus | Cytoplasm | Nucleus and cytoplasm co-expression | ||||||
Age (years) | <60 | 63 | 32(50.8) | 31(49.2) | 0.292 | 62 | 25(40.3) | 12(19.4) | 25(40.3) | 0.362 |
ā„60 | 66 | 27(40.9) | 39 (59.1) | 61 | 18(29.5) | 11 (18.0) | 32 (52.5) | |||
Gender | Male | 116 | 55(47.4) | 61 (52.6) | 0.380 | 110 | 40(36.4) | 21 (19.1) | 49 (44.5) | 0.497 |
Female | 13 | 4(30.8) | 9 (69.2) | 13 | 3(23.1) | 2 (15.4) | 8 (61.5) | |||
pT stage | T2 | 80 | 43(53.8) | 37(46.3) | 0.028 | 77 | 30(39.0) | 18(23.4) | 29(37.7) | 0.035 |
T3~4 | 49 | 16(32.7) | 33(67.3) | 46 | 13(28.3) | 5(10.9) | 28(60.9) | |||
pN stage | Nā | 111 | 55(49.5) | 56(50.5) | 0.041 | 105 | 39(37.1) | 22(21.0) | 44(41.9) | 0.050 |
N+ | 11 | 4(22.2) | 14(77.8) | 18 | 4(6.3) | 1(5.6) | 13(72.2) | |||
Grade | Low | 32 | 12(37.5) | 20(62.5) | 0.312 | 31 | 11(35.5) | 4(12.9) | 16(51.6) | 0.608 |
High | 97 | 47(48.5) | 50(51.5) | 92 | 32(34.8) | 19(20.7) | 41(44.6) | |||
Smoking history | Yes | 68 | 29(42.6) | 39(57.4) | 0.483 | 65 | 23(35.4) | 12(18.5) | 30(46.2) | 0.994 |
No | 61 | 30(49.2) | 31(50.8) | 58 | 20(34.5) | 11(19.0) | 27(46.6) | |||
Gross hematuria | Yes | 102 | 43(42.2) | 59(57.8) | 0.132 | 97 | 32(33.0) | 19(49.5) | 46(47.4) | 0.664 |
No | 27 | 16(59.3) | 11(40.7) | 26 | 11(42.3) | 4(15.4) | 11(42.3) | |||
UIS | Yes | 18 | 8(44.4) | 10(55.6) | 1.000 | 17 | 5(29.4) | 2(11.8) | 10(58.8) | 0.511 |
No | 111 | 51(45.9) | 60(54.1) | 106 | 38(35.8) | 21(19.8) | 47(44.3) | |||
Tumor multiplicity | Yes | 70 | 34(48.6) | 36(51.4) | 0.595 | 66 | 18(27.3) | 16(24.2) | 32(48.5) | 0.087 |
No | 59 | 25(42.4) | 34(57.6) | 57 | 25(43.9) | 7(12.3) | 25(43.9) | |||
Adjuvant chemotherapy | Yes | 39 | 13(33.3) | 26(66.7) | 0.083 | 37 | 13(35.1) | 4(10.8) | 20(54.1) | 0.295 |
No | 90 | 46(51.1) | 44(48.9) | 86 | 30(34.9) | 19(22.1) | 37(43.0) | |||
Tumor recurrence | Yes | 35 | 9(25.7) | 26(74.3) | 0.006 | 32 | 6(18.8) | 5(15.6) | 21(65.6) | 0.031 |
No | 94 | 50(53.2) | 44(46.8) | 91 | 37(40.7) | 18(19.8) | 36(39.6) | |||